lisofylline has been researched along with Asthma, Bronchial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hińcza, K; Kądziołka, D; Koczurkiewicz, P; Madeja, Z; Michalik, M; Pękala, E; Sanak, M; Wnuk, D; Wójcik-Pszczoła, K | 1 |
1 other study(ies) available for lisofylline and Asthma, Bronchial
| Article | Year |
|---|---|
Pentoxifylline and its active metabolite lisofylline attenuate transforming growth factor β1-induced asthmatic bronchial fibroblast-to-myofibroblast transition.
Topics: Anti-Asthmatic Agents; Asthma; Cell Differentiation; Cell Proliferation; Drug Evaluation, Preclinical; Humans; Myofibroblasts; Pentoxifylline; Transforming Growth Factor beta1 | 2016 |